Nimodipine in animal model experiments of focal cerebral ischemia: A systematic review

Stroke

Volumn 32, Issue 10, 2001, Pages 2433-2438

  Horn, J ^a,c   De Haan, R J ^a   Vermeulen, M ^a   Luiten, P G M ^b   Limburg, M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Animal models; Calcium channel blockers; Cerebrovascular disorders; Meta analysis; Nimodipine

Indexed keywords

NIMODIPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; BRAIN EDEMA; BRAIN INFARCTION; BRAIN ISCHEMIA; CLINICAL TRIAL; MEDICAL RESEARCH; METHODOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; STROKE; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0034792905     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/hs1001.096009     Document Type: Review

References (56)

1. Thresholds in cerebral ischaemia: The ischemic penumbra
2. A controlled trial of nimodipine in acute ischemic stroke
3. Clinical trial of nimodipine in acute ischemic stroke: The American nimodipine study group
4. Randomised, double-blind, placebo-controlled trial of nimodipine in acute stroke
5. Flunarizin in stroke treatment (FIST): A double-blind, placebo-controlled trial in Scandinavia and the Netherlands
6. Isradipine in patients with acute ischaemic cerebral infarction: An overview of the ASCLEPIOS programme
7. Calcium antagonists for acute ischemic stroke
8. Meta-analysis of oral nimodipine trials in acute ischemic stoke
9. Termination of acute stroke studies involving selfotel treatment: ASSIST Steering Committee
10. Multinational randomised trial of Lubeluzole in acute ischaemic stroke
11. Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: A randomised controlled trial: GAIN International Investigators
12. Selfotel in acute ischemic stroke: Possible neurotoxic effects of an NMDA antagonist
13. Recommendations for standards regarding preclinical neuroprotective and restorative drug development
14. Meta-analysis in clinical trials
15. Neuroprotection as initial therapy in acute stroke: Third report of an Ad Hoc Consensus Group Meeting
16. Effect of nimodipine on intracellular brain pH, cortical blood flow, and EEG in experimental focal cerebral ischemia
17. Intracellular brain pH and ischemic vasoconstriction in the white New Zealand rabbit
18. Effect of nimodipine on ischemia-induced brain edema and mortality in a novel transient middle cerebral artery occlusion model
19. Nimodipine prevents postischemic brain damage in the early phase of focal cerebral ischemia
20. Nimodipine attenuates both ischaemia-induced brain oedema and mortality in a rat novel transient middle cerebral artery occlusion model
21. Cytosolic free calcium during focal cerebral ischemia and the effects of nimodipine on calcium and histologic damage
22. Intracellular calcium and pathophysiological changes in cerebral ischemia
23. Nimodipine attenuates both increase in cytosolic free calcium and histologic damage following focal cerebral ischemia and reperfusion in cats
24. Combined therapy with MK-801 and nimodipine for protection of ischemic brain damage
25. Effects of calcium channel blockers on neurologic outcome after focal ischemia in rabbits
26. The effects of chlormethiazole and nimodipine on cortical infarct area after focal cerebral ischaemia in the rat
27. Effect of dl-3-n-butylphthalide on brain edema in rats subjected to focal cerebral ischemia
28. Nimodipine and the haemodynamic and histopathological consequences of middle cerebral artery occlusion in the rat
29. Calcium channel blockers correct acidosis in ischemic rat brain without altering cerebral blood flow
30. Nimodipine prevents hyperglycemia-induced cerebral acidosis in middle cerebral artery occluded rats
31. Cerebral acidosis in focal ischemia, II: Nimodipine and verapamil normalize cerebral pH following middle cerebral artery occlusion in the rat
32. Calcium antagonists reduce the extent of infarction in rat middle cerebral artery occlusion model as determined by quantitative magnetic resonance imaging
33. Nimodipine posttreatment does not increase blood flow in rats with focal cortical ischemia
34. Effect of the calcium entry blocker NB-818 on cerebral blood flow after unilateral carotid occlusion in the Mongolian gerbil
35. Therapeutic value of a constant intravenous infusion of nimodipine for 24 hours after acute cerebral infarction
36. The effects of nimodipine, mannitol and their combination on experimental cerebral ischaemia
37. The therapeutic value of nimodipine in experimental focal cerebral ischemia: Neurological outcome and histopathological findings
38. Magnetic resonance imaging in the evaluation of nimodipine-treated acute experimental focal cerebral ischemia
39. Lack of effect of nimodipine in experimental regional cerebral ischemia
40. Neuroprotection disappointment yet aGAIN
41. The existence of publication bias and risk factors for its occurrence
42. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?
43. Why model strokes?
44. Animal models of stroke: Are they relevant to human disease?
45. Animal stroke models: They are relevant to human disease
46. Animal stroke models
47. Why do all drugs work in animal models but none in stroke patients?: Neuroprotective therapy
48. Clinical trials with neuroprotective agents in acute ischaemic stroke: Are we doing the right thing?
49. Effect of nimodipine on postischemic cerebrovascular reactivity, as revealed by measuring regional cerebral blood flow (rCBF)
50. The effects of nimodipine on the clinical course of patients with acute ischemic stroke
51. Nimodipine in acute ischemic stroke: A double-blind controlled study
52. The effects of nimodipine in acute experimental cerebral ischemia in the rat
53. Intravenous Nimodipine West European Stroke Trial (INWEST) of nimodipine in the treatment of acute ischaemic stroke
54. Nimodipine in the treatment of acute MCA ischemic stroke: Nimodipine European Stroke trial group
55. Synergic activity of combined prostacyclin: Dimethyl sulfoxide in experimental brain ischemia
56. Reduction of infarct size by intra-arterial nimodipine administered at reperfusion in a rat model of partially reversible brain focal ischemia